Table 2.
Crude clinical outcomes of ARDS patients by CMV reactivation status
| Reactivation | Non-reactivation | p value | |
|---|---|---|---|
| Death on ventilator before day 30a | 23/74 (31) | 29/197 (15) | <0.01 |
| Death in ICUb | 26/76 (34) | 32/195 (16) | <0.01 |
| Death by day 90b | 35/76 (46) | 55/195 (28) | <0.01 |
| Duration of mechanical ventilation (days) | 15 (10–26) | 8 (6–12) | <0.01 |
| Length of stay in ICU (days) | 16 (11–28) | 9 (7–14) | <0.01 |
aPrimary study end point
bCMV reactivation occurred in two additional patients after successful weaning in the ICU; therefore, 76 instead of 74 patients were considered exposed for analyses with more distal end points (death in ICU, death by day 90). Data show absolute numbers (%) or medians (interquartile range)